We are a clinical-stage, AI-native biopharma that mines massive data for therapeutic gold to raise the standard of cancer care.
Our platform uses AI and available, heterogenous human disease data to uncover novel drug candidates for the most responsive patients, leading to smarter drug discovery that maximizes clinical trial success.
We are currently focused on advancing better therapies for cancers and cancer-related diseases. Our lead program, AU-409, for liver cancer, is in Phase 1 clinical studies.
Company Details
- Employees
- 10
- Address
- 1726 Edgewood Drive, Palo Alto,california 94303,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.auransa.com
- HQ
- Palo Alto, California
Auransa Questions
Auransa's website is http://www.auransa.com
Auransa's LinkedIn profile is https://www.linkedin.com/company/auransa
Auransa has
10 employees.
View email and phone details for 10
employees at Auransa.
Auransa's industry is
Biotechnology Research
Auransa's top competitors are
Capacity Bio,
Pharos Ibio,
Cyclica (Acquired By Recursion, Nasdaq: Rxrx),
Enveda,
Iktos,
Benevolentai,
Generation Bio,
Bluejay Therapeutics,
Exscientia,
Greenstone Biosciences.
Auransa's categories are Biotechnology Research
